Ultratech re-enters race to buy Orient Cement
UltraTech’s spokesperson was unavailable for comment. Deepak Khetrapal, MD and CEO of OCL, denied discussions were taking place and any talk of sale plans was a “figment of one’s imagination.”
UltraTech’s spokesperson was unavailable for comment. Deepak Khetrapal, MD and CEO of OCL, denied discussions were taking place and any talk of sale plans was a “figment of one’s imagination.”
Post Comment